Global Scar Treatment Market registers progress
Global Scar Treatment Market register a healthy CAGR progress of 7.6% during 2017-2025; driven by increasing awareness of personal care and Healthy Economic Growth in Asia Pacific.
Market Introduction
The Global Scar Treatment Market has been analysed to gain an understanding about the changing scenario of the appearance and aesthetic corrective procedures. Scar revision is a procedure that is used to minimize the scars in a way that they appear more consistent with the surrounding skin tone and texture. Scars are visible signs that remain after a wound heals. They are unavoidable results of an injury or a surgery and their development can be unpredictable. Scars may be raised or recessed, different in color or texture from the surrounding healthy tissue, or particularly noticeable due to their size, shape, or location. The market has been segmented by product type, scar type, end-users, and by geographical regions.
Market Value and Forecast
The global scar treatment market is valued at US$ 9654.6 Mn in 2017 and is projected to expand at a robust CAGR of 7.6% over the forecast period of 2017–2025 to reach a valuation of more than US$ 13 Bn by the end of the forecasted year.
Market Dynamics
Growth in revenue generated from the sales of scar treatment products and services is directly attributed to the increasing economic growth and rising personal disposable income levels at a global level. While treatment of burned scars and keloids is considered to be medically necessary by regulatory bodies, treatment of spot correction, mild-to-medium acne is not deemed as a medical necessity. Rise in affluent population has also been responsible for further fuelling the demand for aesthetic corrective procedures such as volume restoration, dermal filling, laser treatments, and wrinkle reduction. Hyaluronic acid based dermal fillers and botulinum type-A injections are prime examples of the same. Markets across the world are also witnessing growth in demand for combination therapeutics in scar treatments, with a view to increase effectiveness of the procedure and shorten the treatment duration.
International regulatory benchmarking for uniform treatment guidelines and shortening of approval times are trends expected to prevail in the industry over the forecast period. This is expected to be accompanied with standardized documentation of clinical evidences of various combination therapeutics related to pharmacovigilance activities.
